Seasoned clinical laboratory executive to drive company’s growth

Executive recruitment firm Slone Partners is pleased to announce the placement of Matthew Watson, an accomplished healthcare leader and entrepreneur with extensive clinical laboratory experience, as Chief Executive Officer of Westox Labs.

Westox Labs is a fast-growing Southern California toxicology company offering a full line of superior laboratory-based and onsite drug testing solutions. Dedicated to providing first class service and support, the organization uses the most advanced laboratory technology paired with premier quality control mechanisms to ensure a high level of accuracy and consistency.

In his new role, Mr. Watson will lead and oversee all aspects of the business including sales, marketing, operations, finance, billing, and compliance. His leadership and input will be called upon across all business units as Westox continues its trajectory toward sustained growth.

“I am extremely excited by this opportunity and honored to follow in the footsteps of current CEO, Mike Gilles, who, together with his senior leadership team, has created a toxicology laboratory of the highest quality. I plan on building on Mike’s success by significantly expanding Westox’s market reach while maintaining the quality, turnaround time, and customer service the company has become known for. I am grateful to Slone Partners for connecting me with an organization that is a perfect fit for my background, experience and management style,” stated Mr. Watson.

With over 25 years of experience, Mr. Watson is a veteran healthcare executive and entrepreneur who has led and counseled several organizations. Prior to joining Westox Labs, he served as a Clinical Laboratory Consultant, where he provided professional consulting services on strategic planning, laboratory design and implementation, billing and reimbursement strategy, operations management, and more. Before offering his consulting services, he founded and acted as CEO of PathCentral, Inc., a national provider of integrated pathology business solutions. He also served as CEO of Pathology Business Services, founded and acted as CEO of Combimatrix Molecular Diagnostics, and worked as COO at US LABS (now LabCorp/Integrated Oncology).

Mr. Watson received a bachelor of arts in biology from Eastern Connecticut State University, a MBA from the University of Hartford, and completed the Executive Program in Leadership at the Stanford University Graduate School of Business.

About Slone Partners

Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for the diagnostics, life science tools, clinical trials, contract research, healthcare information technology and laboratory testing industries with offices in Boston, Washington, D.C. and San Francisco.

Related content: Slone Partners Places New Chief Commercial Officer at Clinical Genomics